SIMPLEX TRADING, LLC - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 32 filers reported holding INMUNE BIO INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of INMUNE BIO INC
ValueSharesWeighting
Q3 2023$81
+224.0%
12,089
+333.3%
0.00%
Q2 2023$25
+92.3%
2,790
+30.4%
0.00%
Q1 2023$13
-23.5%
2,140
-23.8%
0.00%
Q4 2022$17
-99.9%
2,807
+28.8%
0.00%
Q3 2022$13,000
-76.4%
2,179
-65.4%
0.00%
Q2 2022$55,000
-71.6%
6,292
-72.8%
0.00%
Q1 2022$194,000
+743.5%
23,115
+900.6%
0.00%
Q4 2021$23,000
-83.0%
2,310
-68.6%
0.00%
Q3 2021$135,000
+14.4%
7,366
+8.9%
0.00%
Q2 2021$118,0006,7660.00%
Other shareholders
INMUNE BIO INC shareholders Q3 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 275,000$5,341,0002.77%
Fermata Advisors, LLC 12,830$249,0000.11%
DG Capital Management, LLC 20,000$388,0000.08%
YorkBridge Wealth Partners, LLC 10,369$201,0000.05%
Ikarian Capital, LLC 26,632$517,0000.04%
Financial Advocates Investment Management 16,667$324,0000.02%
Janney Montgomery Scott LLC 99,323$1,929,0000.01%
Belvedere Trading LLC 16,177$302,0000.01%
FNY Investment Advisers, LLC 800$15,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 17,200$334,0000.01%
View complete list of INMUNE BIO INC shareholders